OpenLB
Open Library of Bioscience

Preoperative low plasma creatine kinase levels predict worse survival outcomes in bladder cancer after radical cystectomy.

Abstract

Keywords

References

1. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Seisen T, Soukup V, Sylvester RJ (2022) European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in Situ). Eur Urol 81(1):75–94. https://doi.org/10.1016/j.eururo.2021.08.010 [DOI: 10.1016/j.eururo.2021.08.010]
2. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA:A Cancer J Clin 72(1):7–33. https://doi.org/10.3322/caac.21708 [DOI: 10.3322/caac.21708]
3. Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskimäe E, Ribal MJ, van der Heijden AG (2021) European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol 79(1):82–104. https://doi.org/10.1016/j.eururo.2020.03.055 [DOI: 10.1016/j.eururo.2020.03.055]
4. Ploussard G, Shariat SF, Dragomir A, Kluth LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K, Kikuchi E, Klatte T, Boorjian SA, Lotan Y, Roghmann F, Fairey AS, Fradet Y, Black PC, Rendon R, Izawa J, Kassouf W (2014) Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol 66(2):361–370. https://doi.org/10.1016/j.eururo.2013.09.050 [DOI: 10.1016/j.eururo.2013.09.050]
5. Moschini M, Afferi L, Gandaglia G, D’Andrea D, Zamboni S, Di Bona C, Mordasini L, Mattei A, Baumeister P, Martini A, Burgio G, Shariat SF, Sanchez-Salas R, Cathelineau X, Stabile A, Zaffuto E, Salonia A, Colombo R, Necchi A, Montorsi F, Gallina A (2021) Prediction of the need for an extended lymphadenectomy at the time of radical cystectomy in patients with bladder cancer. Euro Urol Focus 7(5):1067–1074. https://doi.org/10.1016/j.euf.2020.09.009 [DOI: 10.1016/j.euf.2020.09.009]
6. Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK, International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group), European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group, Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, Club Urologico Espanol de Tratamiento Oncologico Group (2011) International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol : Off J Am Soc Clin Oncol 29(16):2171–2177. https://doi.org/10.1200/JCO.2010.32.3139 [DOI: 10.1200/JCO.2010.32.3139]
7. Schuettfort VM, D’Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, König F, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF (2022) A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma. BJU Int 129(2):182–193. https://doi.org/10.1111/bju.15379 [DOI: 10.1111/bju.15379]
8. Zhang W, Wang R, Ma W, Wu Y, Maskey N, Guo Y, Liu J, Mao S, Zhang J, Yao X, Liu Y (2019) Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy. Ann Transl Med 7(18):431. https://doi.org/10.21037/atm.2019.09.02 [DOI: 10.21037/atm.2019.09.02]
9. Peng L, Du C, Meng C, Li J, You C, Li X, Zhao P, Cao D, Li Y (2021) Controlling nutritional status score before receiving treatment as a prognostic indicator for patients with urothelial cancer: an exploration evaluation methods. Front Oncol 11:702908. https://doi.org/10.3389/fonc.2021.702908 [DOI: 10.3389/fonc.2021.702908]
10. Peng D, Gong YQ, Hao H, He ZS, Li XS, Zhang CJ, Zhou LQ (2017) Preoperative prognostic nutritional index is a significant predictor of survival with bladder cancer after radical cystectomy: a retrospective study. BMC Cancer 17(1):391. https://doi.org/10.1186/s12885-017-3372-8 [DOI: 10.1186/s12885-017-3372-8]
11. Kazak L, Cohen P (2020) Creatine metabolism: energy homeostasis, immunity and cancer biology. Nat Rev Endocrinol 16(8):421–436. https://doi.org/10.1038/s41574-020-0365-5 [DOI: 10.1038/s41574-020-0365-5]
12. Yan YB (2016) Creatine kinase in cell cycle regulation and cancer. Amino Acids 48(8):1775–1784. https://doi.org/10.1007/s00726-016-2217-0 [DOI: 10.1007/s00726-016-2217-0]
13. Yamazaki N, Oshima Y, Shiratori F, Nanami T, Suzuki T, Yajima S, Funahashi K, Shimada H (2022) Prognostic significance of preoperative low serum creatine kinase levels in gastric cancer. Surg Today 52(11):1551–1559. https://doi.org/10.1007/s00595-022-02505-8 [DOI: 10.1007/s00595-022-02505-8]
14. Murayama K, Suzuki T, Yajima S, Oshima Y, Nanami T, Shiratori F, Shimada H (2022) Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma. Esophagus : Off J Japan Esophageal Soc 19(1):105–112. https://doi.org/10.1007/s10388-021-00866-6 [DOI: 10.1007/s10388-021-00866-6]
15. Liu L, He Y, Ge G, Li L, Zhou P, Zhu Y, Tang H, Huang Y, Li W, Zhang L (2017) Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: a retrospective observational study. PLoS ONE 12(8):e0182168. https://doi.org/10.1371/journal.pone.0182168 [DOI: 10.1371/journal.pone.0182168]
16. Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Tagawa T, Oda Y, Maehara Y (2019) A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase. J Thorac Dis 11(3):927–935. https://doi.org/10.21037/jtd.2019.01.76 [DOI: 10.21037/jtd.2019.01.76]
17. Pan H, Xia K, Zhou W, Xue J, Liang X, Cheng L, Wu N, Liang M, Wu D, Ling L, Ding Q, Chen L, Zha X, Liu X, Wang S (2013) Low serum creatine kinase levels in breast cancer patients: a case-control study. PLoS ONE 8(4):e62112. https://doi.org/10.1371/journal.pone.0062112 [DOI: 10.1371/journal.pone.0062112]
18. Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, Volanis D, Cussenot O, Subiela Henríquez JD, de la Peña E, van Rhijn BWG (2021) European association of urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Euroean Urol 79(4):480–488. https://doi.org/10.1016/j.eururo.2020.12.033 [DOI: 10.1016/j.eururo.2020.12.033]
19. Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27–47. https://doi.org/10.1016/j.cmet.2015.12.006 [DOI: 10.1016/j.cmet.2015.12.006]
20. Wang Z, Hulsurkar M, Zhuo L, Xu J, Yang H, Naderinezhad S, Wang L, Zhang G, Ai N, Li L, Chang JT, Zhang S, Fazli L, Creighton CJ, Bai F, Ittmann MM, Gleave ME, Li W (2021) CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. Neoplasia (New York, N.Y.) 23(11):1147–1165. https://doi.org/10.1016/j.neo.2021.09.005 [DOI: 10.1016/j.neo.2021.09.005]
21. Pavón MA, Parreño M, Téllez-Gabriel M, León X, Arroyo-Solera I, López M, Céspedes MV, Casanova I, Gallardo A, López-Pousa A, Mangues MA, Quer M, Barnadas A, Mangues R (2016) CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma. Head Neck 38(Suppl 1):E1392–E1403. https://doi.org/10.1002/hed.24232 [DOI: 10.1002/hed.24232]
22. Lillie JW, O’Keefe M, Valinski H, Hamlin HA Jr, Varban ML, Kaddurah-Daouk R (1993) Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors. Can Res 53(13):3172–3178
23. Enns DL, Tiidus PM (2010) The influence of estrogen on skeletal muscle: sex matters. Sports Med (Auckland, N.Z.) 40(1):41–58. https://doi.org/10.2165/11319760-000000000-00000 [DOI: 10.2165/11319760-000000000-00000]

Grants

1. 82070784/National Natural Science Foundation of China
2. 81702536/National Natural Science Foundation of China
3. 81974099/National Natural Science Foundation of China
4. 82170785/National Natural Science Foundation of China
5. 2022JDRC0040/Science & Technology Department of Sichuan Province, China
6. 21GJHZ0246/Science and Technology Department of Sichuan Province
7. 2017SCU04A17/Young Investigator Award of Sichuan University 2017
8. 2020CDPZH-4/Sichuan University--Panzhihua science and technology cooperation special fund
9. 2021M692306/China Postdoctoral Science Foundation
10. 2021HXBH025/Post-Doctor Research Project of West China Hospital of Sichuan University

MeSH Term

Chemicals